Inventor · disambiguated record
Diljeet Singh Athwal
Also filed as: ATHWAL DILJEET S · ATHWAL DILJEET SINGH
21 granted patents·8 pending applications·4,606 citations·filing 1993–2021
97Inventor score
Files withCELLTECH R&D LTD13CELLTECH THERAPEUTICS LTD6C2N DIAGNOSTICS LLC2UCB Biopharma SRL2CELLTECH CHIROSCIENCE LTD1
Top patents by PatentIndex Score
29 records- 0199US6632927B2Humanized antibodiesCELLTECH THERAPEUTICS LTD·Filed 2001·Granted Oct 14, 2003·809 cites·7 claims
- 0299US5859205AHumanised antibodiesCELLTECH LTD·Filed 1994·Granted Jan 12, 1999·2.3k cites·8 claims
- 0398US5929212ACD3 specific recombinant antibodyCELLTECH THERAPEUTICS LTD·Filed 1993·Granted Jul 27, 1999·298 cites·13 claims
- 0497US7262050B2Humanised antibodiesCELLTECH R&D LTD·Filed 2003·Granted Aug 28, 2007·53 cites·7 claims
- 0597US5994510ARecombinant antibodies specific for TNFαCELLTECH THERAPEUTICS LTD·Filed 1995·Granted Nov 30, 1999·233 cites·3 claims
- 0696US6180377B1Humanized antibodiesCELLTECH THERAPEUTICS LTD·Filed 1993·Granted Jan 30, 2001·473 cites·17 claims
- 0795US7244615B2Humanized antibodiesCELLTECH R&D LTD·Filed 2003·Granted Jul 17, 2007·30 cites·7 claims
- 0895US7241877B2Humanised antibodiesCELLTECH R&D LTD·Filed 2003·Granted Jul 10, 2007·32 cites·7 claims
- 0994US7244832B2Humanised antibodiesCELLTECH R&D LTD·Filed 2003·Granted Jul 17, 2007·32 cites·7 claims
- 1093US6750325B1CD3 specific recombinant antibodyCELLTECH R&D LTD·Filed 1999·Granted Jun 15, 2004·118 cites·9 claims
- 1192US7566771B1Humanised antibodiesCELLTECH R&D LTD·Filed 1995·Granted Jul 28, 2009·73 cites·19 claims
- 1292US7012135B2Biological productsCELLTECH CHIROSCIENCE LTD·Filed 2001·Granted Mar 14, 2006·63 cites·3 claims
- 1388USRE48787EHumanised antibodiesUCB Biopharma SRL·Filed 2019·Granted Oct 26, 2021·2 cites·19 claims
- 1482USRE50178EHumanised antibodiesUCB Biopharma SRL·Filed 2021·Granted Oct 22, 2024·0 cites·20 claims
- 1581US7977464B2Antibody molecules specific to human tumour necrosis factor alphaUCB PHARMA SA·Filed 2008·Granted Jul 12, 2011·3 cites·22 claims
- 1679US6734286B2Interleukin-5 specific recombinant antibodiesCELLTECH R&D LTD·Filed 2001·Granted May 11, 2004·9 cites·7 claims
- 1778USRE39548EInterleukin-5 specific recombinant antibodiesCELLTECH R&D LTD·Filed 2001·Granted Apr 3, 2007·4 cites·7 claims
- 1876US9957317B2Humanized anti-tau antibodiesC2N DIAGNOSTICS LLC·Filed 2016·Granted May 1, 2018·2 cites·12 claims
- 1976US7186820B2Production of humanised antibodies to TNFαUCB CELLTECH·Filed 2001·Granted Mar 6, 2007·10 cites·12 claims
- 2070US2005136054A1Humanised antibodiesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 2170US2005123534A1Humanised antibodiesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 2270US2006029593A1Humanised antibodiesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 2365US5998586AInterleukin-5 specific recombinant antibodiesCELLTECH THERAPEUTICS LTD·Filed 1995·Granted Dec 7, 1999·17 cites·4 claims
- 2464US2006073136A1Humanised antibodiesCELLTECH R&D LTD·Filed 2005·Application pending·0 cites
- 2564US2006073137A1Humanised antibodiesCELLTECH R&D LTD·Filed 2005·Application pending·0 cites
- 2656US6316227B1Nucleic acids encoding interleukin-5 specific recombinant antibodiesCELLTECH THERAPEUTICS LTD·Filed 1999·Granted Nov 13, 2001·9 cites·8 claims
- 2746US2018371066A1Humanized anti-tau antibodiesC2N DIAGNOSTICS LLC·Filed 2018·Application pending·0 cites
- 2844US2003199679A1Recombinant antibodies specific for TNF-alphaFiled 2003·Application pending·0 cites
- 2930US2002099179A1Cdr-grafted antibodiesFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →